Akamai Closes Upsized $2.5B Convertible Notes, Nets $2.46B for 2027 Debt and Cloud Capex
AKAM is trading near its 52-week low of $77.37 (12% above the low).
Summary
Akamai closed an upsized $2.5B two-tranche convertible offering at a 1.00% coupon, netting about $2.46B to repay 2027 converts and fund cloud capex, with conversion prices of roughly $112.41 and $102.37.
Key Events · Financing and Capital Events · AKAM
-
Upsized $2.5B Convertible Offering Closes
Akamai sold $1.25B of 1.00% notes due 2028 and $1.25B of 1.00% notes due 2031, each including $150.0M from the initial purchasers' option exercised in full — up from the $2.2B announced on November 9.
-
Net Proceeds of About $2.46B
Net proceeds were approximately $2,459.7M after discounts and estimated offering expenses; about $284.4M went to convertible note hedge costs, partially offset by warrant sale proceeds.
-
Conversion Prices Well Above Market
Initial conversion prices are approximately $112.41 for the 2028 notes (40.0% premium) and $102.37 for the 2031 notes (27.5% premium) to the $80.29 closing price on November 9, 2026, versus today's $86.56 quote.
-
Proceeds Target 2027 Converts and Cloud Capex
Remaining proceeds repay at maturity a portion of the $1.15B of 0.375% convertible notes due September 1, 2027 and/or cash due on earlier conversion, and fund Cloud Infrastructure Services capital expenditures.
Analysis · AKAM · Trade & Services
Akamai closed a larger deal than the $2.2B it announced on November 9: $2.5B split evenly between 1.00% notes due 2028 and 1.00% notes due 2031, after the initial purchasers exercised their $150M-per-tranche options in full. Net proceeds of about $2.46B fund repayment of the $1.15B of 0.375% converts maturing September 2027 and the capex build-out of Cloud Infrastructure Services, with roughly $284.4M spent on note hedges to blunt conversion dilution. The conversion prices — about $112.41 for the 2028s and $102.37 for the 2031s — sit well above today's $86.56 quote, so the notes are out-of-the-money and the near-term dilution risk is limited to the separately sold warrants. The trade-off is leverage: $2.5B of new senior unsecured debt against a business whose Q3 operating margin was 10%, which is why management is pointing to 2027-2028 EBITDA and cash-flow expansion to de-lever.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AKAM was trading at $86.56 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $12.5B. The 52-week trading range was $77.37 to $165.45. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.